Inventor · disambiguated record
Jeffrey A. Silverman
Also filed as: SILVERMAN JEFFREY · SILVERMAN JEFFREY A
8 granted patents·13 pending applications·31 citations·filing 2005–2024
84Inventor score
Files withSUNESIS PHARMACEUTICALS INC11ADELMAN DANIEL C5JAZZ PHARMACEUTICALS IRELAND LTD3HOCH UTE1SILVERMAN JEFFREY A1
Top patents by PatentIndex Score
21 records- 0191US8124773B21,8-naphthyridine compounds for the treatment of cancerADELMAN DANIEL C·Filed 2007·Granted Feb 28, 2012·10 cites·13 claims
- 0290US7989468B2Methods of using SNS-595SUNESIS PHARMACEUTICALS INC·Filed 2005·Granted Aug 2, 2011·13 cites·43 claims
- 0383US8580814B2Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4- oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancerADELMAN DANIEL C·Filed 2006·Granted Nov 12, 2013·3 cites·24 claims
- 0476US8765954B21,8-naphthyridine compounds for the treatment of cancerADELMAN DANIEL C·Filed 2012·Granted Jul 1, 2014·1 cites·8 claims
- 0576US2025032597A1Recombinant l-asparaginaseJAZZ PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 0675US8518872B2Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-OXO-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapySILVERMAN JEFFREY A·Filed 2008·Granted Aug 27, 2013·4 cites·15 claims
- 0770US2015150858A1Compounds and compositions for treatment of cancerSUNESIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0865US12121571B2Recombinant L-asparaginaseJAZZ PHARMACEUTICALS IRELAND LTD·Filed 2020·Granted Oct 22, 2024·0 cites·32 claims
- 0964US2014378505A1Sns-595 and methods of using the sameSUNESIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1062US9757363B2SNS-595 and methods of using the sameSUNESIS PHARMACEUTICALS INC·Filed 2016·Granted Sep 12, 2017·0 cites·17 claims
- 1161US9676774B2Compounds and compositions for treatment of cancerSUNESIS PHARMACEUTICALS INC·Filed 2016·Granted Jun 13, 2017·0 cites·6 claims
- 1258US2022313798A1Dosing of recombinant l-asparaginaseJAZZ PHARMACEUTICALS IRELAND LTD·Filed 2021·Application pending·0 cites
- 1357US2006025437A1SNS-595 and methods of using the sameADELMAN DANIEL C·Filed 2005·Application pending·0 cites
- 1454US2015190380A1Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of certain hematologic disordersSUNESIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1554US2014205679A1Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapySUNESIS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1653US2014205680A1Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancerSUNESIS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1753US2008063642A1Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of certain hematologic disordersADELMAN DANIEL C·Filed 2007·Application pending·0 cites
- 1851US2018098975A1Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancerSUNESIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1947US2016317510A1Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapySUNESIS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2046US2017119745A1Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of certain hematologic disordersSUNESIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2146US2011293745A1Aurora kinase inhibitorsHOCH UTE·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeffrey A. Silverman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →